Novavax, Inc.

NVAX.MX·Mexico·Healthcare
Compare
189.000.00 (0.00%)today
At close: Oct 30, 1:45 PM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close189.00
Open0.00
Day range0.00189.00
52-week range0.00245.94
Off day high0.00%
Off 52-week high−23.15%
Volume0.00
Avg. volume (3M)981
Market cap31.17B
EPS (TTM)-28.43
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.72
Shares outstanding164.95M
Short interest—
Earnings dateNov 5, 2026
Analyst target—
Profit margin−59.87%

Against its peers

Compare in full ›
NVAX.MX MRNA PCVX BAVA.CO 6547.TWO 688319.SS
Market cap 31.17B 103.15B 10.34B 18.71B 15.63B 12.12B
P/E (TTM) — — — 12.9 — —
Forward P/E — -56.4 -9.2 22.3 32.6 —
Price/book -8.7 15.2 3.2 1.4 4.4 13.4
Dividend yield — — — — — —
1-year change +32.18% +961.98% +57.47% +31.98% +44.00% +22.98%
Today 0.00% +13.11% +8.01% +1.62% −2.16% +6.03%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All NVAX.MX news ›
StockStory·Positive

Novavax (NVAX) reports earnings tomorrow: what to expect

Vaccine biotechnology company Novavax (NASDAQ:NVAX) will be reporting earnings this Thursday before market hours. Here’s what you need to know. Novavax beat analysts’ revenue expectations last quarter, reporting revenues of $56.7 million,…

AOL.com··2 outletsPositive

Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe

Novavax (Nasdaq: NVAX) has earned a $125 million milestone payment with the initiation (fifth patient dosed) of Sanofi's Phase 3 influenza-COVID-19 combination vaccine trial utilizing Novavax's ... The global flu and COVID-19 markets have…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

44mentions in 30 days
36with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 44 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance